Pharmacotherapy of pathological gambling: review of new treatment modalities

References

• Shaffer HJ, Hall MN, Vander Bilt J. Estimating the prevalence of disorder gambling behavior in the United States and Canada: a research synthesis. Am. J. Public Health89, 1369–1376 (1999).
   PubMed Web of Science ®Google Scholar
• Hollander E, Buchalter AJ, DeCaria CM. Pathological gambling. Psychiatr. Clin. North Am.23(3), 629–642 (2000).
   PubMed Web of Science ®Google Scholar
• World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. World Health Organization, Geneva, Switzerland (1992).
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). American Psychiatric Association Inc., DC, USA (1994).
   Google Scholar
• Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibanez A. Pathological gambling: addiction or compulsion? Semin. Clin. Neuropsychiatry6(3), 167–176 (2001).
   PubMedGoogle Scholar
• Grant JE, Kim SW. Comorbidity of impulse control disorders in pathological gamblers. Acta Psychiatr. Scand.108(3), 203–207 (2003).
   PubMed Web of Science ®Google Scholar
• Sood ED, Pallanti S, Hollander E. Diagnosis and treatment of pathologic gambling. Curr. Psychiatry Rep.5(1), 9–15 (2003).
   PubMedGoogle Scholar
• Dannon PN, Lowengrub K, Sasson M et al. Comorbid psychiatric diagnoses in kleptomania and pathological gambling: a preliminary comparison study. Eur. Psychiatry19(5), 299–302 (2004).
   PubMed Web of Science ®Google Scholar
• Dannon PN, Iancu I, Lowengrub K, Mester R, Kotler M. Pathological gambling: comorbid psychiatric diagnoses in patients and their families. Isr. J. Phychiatry Relat. Sci.43(2), 88–92 (2006).
   Google Scholar
• Shah KR, Eisen SA, Xian H, Potenza MN. Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam era twin registry. J. Gambl. Stud.21(2), 179–203 (2005).
   PubMed Web of Science ®Google Scholar
• Black DW, Monahan PO, Temkit M, Shaw M. A family study of pathological gambling. Psychiatry Res.141(3), 295–303 (2006).
   PubMed Web of Science ®Google Scholar
• Scherrer JF, Xian H, Shah KR, Volberg R, Slutske W, Eisen SA. Effect of genes, environment, and lifetime co-occurring disorders on health-related quality of life in problem and pathological gamblers. Arch. Gen. Psychiatry62(6), 677–683 (2005).
   PubMed Web of Science ®Google Scholar
• Hollander E, Wong CM. Obsessive–compulsive spectrum disorders. J. Clin. Psychiatry56(Suppl. 4), 3–6, discussion 53–55 (1995).
   PubMed Web of Science ®Google Scholar
• Blaszczynski A. Pathological gambling and obsessive-compulsive spectrum disorders. Psychol. Rep.84(1), 107–113 (1999).
   PubMed Web of Science ®Google Scholar
• Frost RO, Meagher BM, Riskind JH. Obsessive-compulsive features in pathological lottery and scratch-ticket gamblers. J. Gambl. Stud.17(1), 5–19 (2001).
   PubMedGoogle Scholar
• Tamminga CA, Nestler EJ. Pathological gambling: focusing on the addiction, not the activity. Am. J. Psychiatry163(2), 180–181 (2006).
   PubMed Web of Science ®Google Scholar
• Petry NM. Should the scope of addictive behaviors be broadened to include pathological gambling? Addiction101(Suppl. 1), 152–160 (2006).
   PubMed Web of Science ®Google Scholar
• Nutt DJ. Addiction: brain mechanisms and their treatment implications. Lancet347(8993), 31–36 (1996).
   PubMed Web of Science ®Google Scholar
• Schultz W. Dopamine neurons and their role in reward mechanisms. Curr. Opin. Neurobiol.7(2), 191–197 (1997).
   PubMed Web of Science ®Google Scholar
• Bechara A. Risky business: emotion, decision-making, and addiction. J. Gambl. Stud.19(1), 23–51 (2003).
   PubMedGoogle Scholar
• Bechara A. Neurobiology of decision-making: risk and reward. Semin. Clin. Neuropsychiatry6(3), 205–216 (2001).
   PubMedGoogle Scholar
• Jentsch JD, Taylor JR. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl.)146(4), 373–390 (1999).
   PubMed Web of Science ®Google Scholar
• Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Decision making in pathological gambling: a comparison between pathological gamblers, alcohol dependents, persons with Tourette syndrome, and normal controls. Brain Res. Cogn. Brain Res.23(1), 137–151 (2005).
   PubMedGoogle Scholar
• Goudriaan AE, Oosterlaan J, de Beurs E, van den Brink W. Neurocognitive functions in pathological gambling: a comparison with alcohol dependence, Tourette syndrome and normal controls. Addiction101(4), 534–547 (2006).
   PubMed Web of Science ®Google Scholar
• Kertzman S, Lowengrub K, Aizer A, Nahum ZB, Kotler M, Dannon PN. Stroop performance in pathological gamblers. Psychiatry Res.142(1), 1–10 (2006).
   PubMed Web of Science ®Google Scholar
• Steel Z, Blaszczynski A. Impulsivity, personality disorders and pathological gambling severity. Addiction93(6), 895–905 (1998).
   PubMed Web of Science ®Google Scholar
• Brand M, Kalbe E, Labudda K, Fujiwara E, Kessler J, Markowitsch HJ. Decision-making impairments in patients with pathological gambling. Psychiatry Res.133, 91–99 (2005).
   PubMed Web of Science ®Google Scholar
• Hollander E, DeCaria CM, Finkell JN, Begaz T, Wong CM, Cartwright C. A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling. Biol. Psychiatry47(9), 813–817 (2000).
   PubMed Web of Science ®Google Scholar
• Blanco C, Petkova E, Ibanez A, Saiz-Ruiz J. A pilot placebo-controlled study of fluvoxamine for pathological gambling. Ann. Clin. Psychiatry14(1), 9–15 (2002).
   PubMedGoogle Scholar
• Kim SW, Grant JE, Adson DE, Shin YC, Zaninelli RM. A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J. Clin. Psychiatry63, 501–507 (2002).
   PubMed Web of Science ®Google Scholar
• Grant JE, Kim SW, Potenza MN et al. Paroxetine treatment of pathological gambling: a multi-centre randomized controlled trial. Int. Clin. Psychopharmacol.18(4), 243–249 (2003).
   PubMed Web of Science ®Google Scholar
• Grant JE, Potenza MN. Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation. Int. Clin. Psychopharmacol.21(4), 203–209 (2006).
   PubMed Web of Science ®Google Scholar
• Pallanti S, Baldini Rossi N, Sood E, Hollander E. Nefazodone treatment of pathological gambling: a prospective open-label controlled trial. J. Clin. Psychiatry63(11), 1034–1039 (2002).
   PubMed Web of Science ®Google Scholar
• Coccaro EF, Kavoussi RJ, Sheline YI, Lish JD, Csernansky JG. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch. Gen. Psychiatry53(6), 531–536 (1996).
   PubMed Web of Science ®Google Scholar
• Anton RF. Pharmacologic approaches to the management of alcoholism. J. Clin. Psychiatry62(Suppl. 20), 11–17 (2001).
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Adson DE, Shin YC. Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol. Psychiatry49(11), 914–921 (2001).
   PubMed Web of Science ®Google Scholar
• Grant JE, Potenza MN, Hollander E et al. Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling. Am. J. Psychiatry163(2), 303–312 (2006).
   PubMed Web of Science ®Google Scholar
• Kim SW, Grant JE, Yoon G, Williams KA, Remmel RP. Safety of high-dose naltrexone treatment: hepatic transaminase profiles among outpatients. Clin. Neuropharmacol.29(2), 77–79 (2006).
   PubMed Web of Science ®Google Scholar
• Zwar N, Richmond R. Buproprion sustained release: a therapeutic review of Zyban. Aus. Fam. Physician31, 443–447 (2002).
   PubMedGoogle Scholar
• The Practitioner’s Guide to Psychoactive Drugs (Fourth Edition). AJ Gelenberg, EL Bassuk (Eds). Plenum Medical Book Company, NY, USA (1997).
   Google Scholar
• Volpicelli JR. Alcohol abuse and alcoholism: an overview. J. Clin. Psychiatry62(Suppl. 20), 4–10 (2001).
   PubMed Web of Science ®Google Scholar
• Tardieu S, Poirier Y, Micallef J, Blin O. Amphetamine-like stimulant cessation in an abusing patient treated with bupropion. Acta Psychiatr. Scand.109(1), 75–77 discussion 7–8 (2004).
   Google Scholar
• Black D. An open-label trial of buproprion in the treatment of pathological gambling. J. Clin. Psychopharmacology24(1), 108–109 (2004).
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Musin E, Gonopolski Y, Kotler M. Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: a preliminary blind-rater study. J. Clin. Psychopharmacol.25(6), 593–596 (2005).
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Sustained release bupropion in the treatment of SSRI nonresponsive pathological gambling: pilot study and review of the literature. Therapy2(5), 753–757 (2005).
   Google Scholar
• Pallanti S, Quercioli L, Sood E, Hollander E. Lithium and valproate treatment of pathological gambling: a randomized single-blind study. J. Clin. Psychiatry63(7), 559–565 (2002).
   PubMed Web of Science ®Google Scholar
• Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am. J. Psychiatry162(1), 137–145 (2005).
   PubMed Web of Science ®Google Scholar
• McElroy SL, Arnold LM, Shapira NA et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am. J. Psychiatry160(2), 255–261 (2003).
   PubMed Web of Science ®Google Scholar
• Dannon PN. Topiramate for the treatment of kleptomania: a case series and review of the literature. Clin. Neuropharmacol.26(1), 1–4 (2003).
   PubMed Web of Science ®Google Scholar
• Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M. Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin. Neuropharmacol.28(1), 6–10 (2005).
   PubMed Web of Science ®Google Scholar
• Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioral treatment of pathological gambling: a controlled study. J. Consult. Clin. Psychol.65(5), 727–732 (1997).
   PubMed Web of Science ®Google Scholar
• Echeburua E, Baez C, Fernandez-Montalvo J. Comparative effectiveness of three therapeutic modalities in the psychological treartment of pathological gambling. Behav. Cog. Psychotherapy24, 51–72 (1996).
   Google Scholar
• Echeburua E, Fernandez-Montalvo J, Baez C. Prevention in the treatment of slot-machine pathological gambling: long-term outcome. Behav. Ther.31, 351–364 (2000).
   Web of Science ®Google Scholar
• Petry NM, Ammerman Y, Bohl J et al. Cognitive-behavioral therapy for pathological gamblers. J. Consult. Clin. Psychol.74(3), 555–567 (2006).
   PubMed Web of Science ®Google Scholar
• McCusker CG. Cognitive biases and addiction: an evolution in theory and method. Addiction96(1), 47–56 (2001).
   PubMed Web of Science ®Google Scholar
• Toneatto T. Cognitive psychopathology of problem gambling. Sub. Use Misuse34(11), 1593–1604 (1999).
   PubMed Web of Science ®Google Scholar
• Milton S, Crino R, Hunt C, Prosser E. The effect of compliance-improving interventions on the cognitive-behavioural treatment of pathological gambling. J. Gambl. Stud.18(2), 207–229 (2002).
   PubMedGoogle Scholar
• Petry NM, Roll JM. A behavioral approach to understanding and treating pathological gambling. Semin. Clin. Neuropsychiatry6(3), 177–183 (2001).
   PubMedGoogle Scholar
• Ladouceur R, Sylvain C, Boutin C, Lachance S, Doucet C, Leblond J. Group therapy for pathological gamblers: a cognitive approach. Behav. Res. Ther.41(5), 587–596 (2003).
   PubMed Web of Science ®Google Scholar
• Kausch O, Rugle L, Rowland DY. Lifetime histories of trauma among pathological gamblers. Am. J. Addict.15(1), 35–43 (2005)
   Google Scholar
• Waska R. Addictions and the quest to control the object. Am. J. Psychoanal.66(1), 43–62 (2006).
   PubMedGoogle Scholar
• Aizer A, Lowengrub K, Dannon PN. Kleptomania after head trauma: two case reports and combination treatment strategies. Clin. Neuropharmacol.27(5), 211–215 (2004).
   PubMed Web of Science ®Google Scholar
• Dell’Osso B, Allen A, Hollander E. Comorbidity issues in the pharmacological treatment of pathological gambling: a critical review. Clin. Pract. Epidemol. Ment. Health1, 21 (2005).
   PubMedGoogle Scholar
• Morasco BJ, Vom Eigen KA, Petry NM. Severity of gambling is associated with physical and emotional health in urban primary care patients. Gen. Hosp. Psychiatry28(2), 94–100 (2006).
   PubMed Web of Science ®Google Scholar
• Weinstock J, Blanco C, Petry NM. Health correlates of pathological gambling in a methadone maintenance clinic. Exp. Clin. Psychopharmacol.14(1), 87–93 (2006).
   PubMed Web of Science ®Google Scholar